Immunic (IMUX) Stock Chart & Stock Price History $0.93 -0.01 (-0.91%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$0.94 +0.01 (+0.81%) As of 08/1/2025 07:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Immunic Stock Price Performance The Immunic (IMUX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 27.79%, with a year-to-date return of -6.85%. In the past month, the stock has increased 30.65%, reflecting recent market activity. As of the latest close, Immunic traded at $0.93 with a market cap of $89.25 million and volume of 668,229 shares. Five years ago, the stock traded at $17.20, representing a 94.58% decrease over that period. At the time, it had a market cap of $257.48 million and a volume of 355,392 shares. Receive IMUX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Immunic and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-13.75%1 Month Performance+30.65%3 Month Performance-19.00%Year-To-Date Performance-6.85%1 Year Performance-27.79%5 Year Performance-94.58% IMUX Stock Chart for Saturday, August, 2, 2025 IMUX Chart by TradingView Immunic Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/01/2025$0.94$0.93-0.91%$0.93$0.89668,229 shs$89.25 million07/31/2025$0.96$0.94-2.23%$0.98$0.92657,213 shs$90.08 million07/30/2025$0.98$0.96-1.82%$1.00$0.95650,275 shs$92.13 million07/29/2025$1.08$0.98-9.32%$1.10$0.941.31 million shs$93.84 million07/28/2025$1.12$1.08-3.57%$1.18$1.061.28 million shs$103.49 million07/25/2025$1.07$1.12+4.67%$1.13$1.04969,448 shs$107.32 million07/24/2025$1.00$1.07+7.32%$1.10$0.991.97 million shs$102.53 million07/23/2025$0.94$1.00+6.51%$1.02$0.951.41 million shs$95.53 million07/22/2025$0.93$0.94+0.48%$0.99$0.931.09 million shs$89.70 million07/21/2025$0.96$0.93-3.36%$1.04$0.902.42 million shs$89.27 million Get the Latest News and Ratings for IMUX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Immunic and its competitors with MarketBeat's FREE daily newsletter. 07/18/2025$0.93$0.96+3.66%$1.00$0.941.81 million shs$92.37 million07/17/2025$0.90$0.93+3.82%$0.98$0.891.29 million shs$89.11 million07/16/2025$0.83$0.90+7.53%$0.92$0.84778,118 shs$85.83 million07/15/2025$0.84$0.83-0.82%$0.86$0.82699,634 shs$79.83 million07/14/2025$0.83$0.84+1.19%$0.84$0.81367,687 shs$80.49 million07/11/2025$0.84$0.83-1.18%$0.85$0.82439,488 shs$79.54 million07/10/2025$0.81$0.84+4.24%$0.85$0.78910,872 shs$80.49 million07/09/2025$0.83$0.81-2.82%$0.83$0.78663,130 shs$77.21 million07/08/2025$0.77$0.83+8.39%$0.83$0.761.13 million shs$79.45 million07/07/2025$0.73$0.77+4.94%$0.78$0.731.30 million shs$73.30 million07/04/2025$0.73$0.73$0.75$0.70635,541 shs$69.85 million07/03/2025$0.71$0.73+2.24%$0.75$0.70635,541 shs$69.85 million07/02/2025$0.69$0.71+3.27%$0.72$0.69776,187 shs$66.15 million07/01/2025$0.70$0.69-1.02%$0.74$0.69962,473 shs$66.15 million Related Companies Fulcrum Therapeutics Stock Price Chart Eton Pharmaceuticals Stock Price Chart COMPASS Pathways Stock Price Chart Aquestive Therapeutics Stock Price Chart SNDL Stock Price Chart Arcturus Therapeutics Stock Price Chart iTeos Therapeutics Stock Price Chart CryoPort Stock Price Chart Vigil Neuroscience Stock Price Chart Humacyte Stock Price Chart Receive IMUX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Immunic and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:IMUX) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immunic, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Immunic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
